AMGNon logo

Amgen Inc (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease;...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

회사 프로필

주식 코드
AMGN
ISIN 코드
US0311621009
통화
US Dollar (USD)
IPO 날짜
1983-06-17

연락처 정보

회사 주소
One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
연락처 전화
805 447 1000
회사 웹사이트
https://www.amgen.com
회계연도말
December

재무 하이라이트

시가총액
$999,999.99
총 이익(TTM)
$999,999.99
배당수익률
2.92%
자산 수익률(TTM)
8.35%
EBITDA
$999,999.99
수익(TTM)
$999,999.99